Complementarity-Determining Region 3 (CDR3) of the Heavy Chain Only Antibodies: Therapeutic Perspectives

.blurhash-client-img { display: none !important; }

Open Access

|Jun 2024

Authors

Laboratory of Biomedical Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Košice, Košice

Laboratory of Biomedical Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Košice, Košice

Laboratory of Biomedical Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Košice, Košice

Laboratory of Biomedical Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Košice, Košice

Institute of Neuroimmunology, Slovak Academy of Sciences v. v. i., Bratislava, Slovakia

DOI: https://doi.org/10.2478/fv-2024-0019 | Journal eISSN: 2453-7837 | Journal ISSN: 0015-5748

Language: English

Page range: 64 - 71

Submitted on: Apr 4, 2024

Accepted on: May 21, 2024

Published on: Jun 27, 2024

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Related subjects:

© 2024 Lea Talpašová, Katarína Bhide, Tomáš Maľarik, Mangesh Bhide, published by The University of Veterinary Medicine and Pharmacy in Košice
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.